Arthritis Foundation Advocate Testifies Before U.S. Food and Drug Administration
Use of her hands meant everything. It’s how she saved lives. It’s how she provided for her family. Susan Behen, MD, trained in general surgery at Johns Hopkins Hospital and held a specialty fellowship...
View ArticleClik here to view.
Pennsylvania Arthritis Advocates Achieve Biosimilar Substitution Success!
Devon Salasin is a junior at Penn State University and a talented snow skier. So good, that she recently placed 23rd out of 107 skiers at the National Collegiate Alpine Race. But skiing wasn’t always...
View ArticleBiosimilar Substitution Victory in Hawaii!
With new, innovative arthritis medications coming to market, patients with arthritis may soon have access to potentially less expensive biosimilar medications. These are medications that are similar...
View ArticleOhio Biosimilar Substitution bill signed into Law by Governor Kasich
Imagine that your pharmacist substituted the biologic drug prescribed by your physician for a different drug, an interchangeable biologic product, without your physician being informed. For many people...
View ArticleVictory in Montana! Governor Bullock Signs Biosimilar Substitution
For years now, many arthritis patients have utilized biologic medications to great effect. Biologics have allowed those with arthritis, as well as many other chronic diseases, to stabilize their...
View ArticleClik here to view.
Victory in Iowa: Biosimilar Legislation Signed Into Law!
Iowa has recently joined 27 other states that have passed biosimilars legislation. On behalf of the 619,000 adults (plus 2,800 children) in Iowa with doctor-diagnosed arthritis, we’d like to thank...
View ArticleVictory for Maryland! Biosimilar Bill Signed by the Governor!
We applaud Maryland Governor Larry Hogan for joining 28 other states in creating a pathway for the substitution of biologic medications with biosimilars by signing the Pharmacists – Substitution and...
View ArticleVictory in New York! Biosimilar Legislation Signed Into Law
On behalf of the more than 3.6 million New Yorkers (including 18,400 children) with doctor-diagnosed arthritis, the Arthritis Foundation thanks Governor Andrew Cuomo for signing biosimilar legislation...
View ArticleArthritis Foundation Plays a Role in CMS Biosimilars Policy Reversal
On Thursday, November 2, the Centers for Medicare and Medicaid Services (CMS) announced they would reverse a policy determining how providers are paid for administering biosimilar drugs under Medicare...
View ArticleBiosimilar Substitution Victories Across the Country!
The Arthritis Foundation thanks the governors in eight states for signing biosimilar legislation in 2018 that enhances patient access to new and innovative medications, while ensuring that pharmacists...
View Article
